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ABSTRACT
Purpose: To evaluate the auditory pathways of children with early-treated phenylketonuria through audiometry, immitance tests, 
and suppression of transient otoacoustic emissions. Methods: Prospective cross-sectional study with sample composed by 28 
children: 12 with phenylketonuria and 16 without the disease. Participants underwent auditory evaluations composed of air- and 
bone-conduction pure-tone audiometry, speech audiometry, immittance tests and suppression of transient otoacoustic emissions. 
Results: All participants presented normal results in pure-tone and speech audiometry; however, speech discrimination scores were 
lower on the phenylketonuria group. Immitance tests revealed normal tympanograms for all children, but stapedial reflex thresholds 
demonstrated higher thresholds in 2 and 4 kHz for children with phenylketonuria. The suppresion of transient otoacoustic emissions 
did not show difference in the comparison between groups. Conclusion: The basic audiologic assessment do not identify hearing 
disorders in children with phenylketonuria; however, speech discrimination scores were lower and stapedial reflexes were higher in 
these children, which may indicate auditory processing disorders. The study of the suppression of transient otoacoustic emissions 
demonstrated integrity of the olivocochlear efferent system in children with phenylketonuria.
Keywords: Hearing; Phenylketonurias; Hair cells, auditory; Hearing disorders; Otoacoustic emissions, spontaneous 
INTRODUCTION
Phenylketonuria (PKU) is a metabolic disease that is gene-
tically transmitted in an autosomal recessive form, caused by a 
mutation in the gene that codes the phenylalanine hydroxylase 
enzyme, which is responsible for transforming the amino acid 
phenylalanine into tyrosine(1,2). Elevated levels of phenyla-
lanine in the blood facilitates the passage of this enzyme in 
excessive amounts into the central nervous system, where its 
accumulation results in a toxic effect with mental retardation 
being the most significant manifestation of this disease(3-5). 
Thus, failure to treat PKU is associated with a high risk of 
damage to cognitive development(6).
In infants with PKU, no apparent abnormalities are obser-
ved at birth, because the mother’s liver protects the fetus(3). 
Undiagnosed children who do not receive early treatment 
may not achieve the necessary initial brain development and 
may present progressive impairment in brain function. When 
the disease is not treated at the right time, symptoms such as 
irritability, learning difficulty, lack of attention, behavioral 
disturbances, hyperactivity, and seizures may occur between 
the ages of 6 and 18 months(3).
Excess levels of phenylalanine and its catabolites in the 
blood has a toxic effect on the somatic functions and central 
nervous system, interferes in cerebral protein synthesis and 
myelination, reduces the formation of serotonin, and alters 
the concentration of amino acids in the spinal fluid. These 
impairments lead to a loss of intellectual functions, locomotion 
and speech in the carrier, together with hyperactivity, tremors, 
microcephaly, growth impairment, and principally, irreversible 
mental retardation of a varying degree and intensity(3).
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PKU is diagnosed using the Teste do Pezinho (Guthrie 
Test), which is mandatory throughout Brazil, as stipulated in 
the Statute on Children and Adolescents)(7). In Minas Gerais, 
this test is performed at the Center for Research in Diagnos-
tic Support of the Faculty of Medicine at the Universidade 
Federal de Minas Gerais (UFMG). Patients with diagnostic 
suspicion are directed to the Special Genetics Department of 
the Hospital das Clínicas (UFMG), where they are evaluated 
by an interdisciplinary team(5).
Treatment for PKU is essentially by maintaining proper 
diet; when initiated at an early stage, which is usually within 
the first 30 days after birth (ideally within the first 21 days), 
this treatment method can even prevent impairments from 
a biochemical as well as clinical point of view. The dietary 
treatment involves the exclusion or substitution of all foods 
containing phenylalanine(8). The treatment has to be maintai-
ned throughout the patient’s life, because even after complete 
neurological development of the individual, presence of high 
levels of phenylalanine can impair cognitive functions. The 
amount of phenylalanine that can be ingested depends on the 
existing plasma levels of phenylalanine, activity of hepatic 
phenylalanine hydroxylase enzyme, and tolerance to phenyla-
lanine, which can vary among individuals(3). Although early 
intervention can prevent clinical manifestations of PKU, some 
children are known to show global development delay and 
hearing and language deficiencies(9).
Because PKU is a disease that compromises the mye-
lination process even in children who are treated early, the 
evaluation of peripheral and central hearing must be performed 
in these children to identify possible hearing impairments. 
Recent studies show the need for further research related to 
the identification of possible deficits involving lesions in other 
areas of the central nervous system, toward more in-depth 
knowledge of the genetics and biochemistry of PKU, need for 
other treatment options, and development of new therapeutic 
strategies for these patients(10-12).
Otoacoustic emissions (OAE) are defined as release of 
sound energy produced in the cochlea that is propagated 
through the middle ear until it reaches the external acoustic 
meatus(13). In normal individuals, these sounds are generated 
spontaneously or in response to an acoustic stimulus by the 
external ciliated cells (ECC) and is captured in the external 
acoustic meatus by amplification, because these sounds are of 
low intensity. The ECC facilitates an increase in the intensity 
of a stimulus to up to 50 dB(13). The ECC amplifies the sounds 
created by movements of the basilar membrane, by quick and 
slow contractions, which are controlled by the efferent audi-
tory system, to aid in frequency selection. The OAE supply 
information on the functioning of the organ of Corti and the 
efferent system(13).
OAE have great importance and is used in the following 
situations: differential diagnosis of peripheral and central he-
aring impairments in children with other disabilities, such as 
autism and encephalopathies, during neonatal and school he-
aring screenings; monitoring cochlear function in individuals 
exposed to extreme noise or medication with ototoxic drugs; 
analysis and diagnosis of sudden and progressive hearing loss; 
cochlear dysfunction due to endolymphatic hydrops and meta-
bolic impairments; and evaluation of the medial olivocochlear 
efferent system(14-16).
Suppression of OAE is characterized by reduction in the 
amplitude of the responses obtained by application of a sti-
mulus ipsilaterally to or against the ear during evaluation in 
individuals with healthy auditory pathways(14). This is because 
of the action of the medial olivocochlear efferent system, 
which functions as a modulator and adjusts the active process 
of the cochlea by slow contractions of the ECC and attenua-
ting the quick contractions. The effect of suppression of the 
OAE is approximately 0.5 to 1 dBNPS(14). Noise as well as 
the stimulus must be presented in low intensities, between 60 
and 65 dBNPS, to avoid the effects of activation of the middle 
ear protection system. A brief stimulus (click) must be used, 
with blank noise as the attenuating noise, which activates the 
olivocochlear system, resulting in suppression(14,15).
The suppression of the OAE provides important infor-
mation about the functioning of the efferent system and the 
interaction between the afferent and efferent pathways, which 
aids in showing the difference between peripheral and central 
hearing losses. No suppression is observed in retrocochlear 
hearing loss in patients who have undergone vestibular neu-
rectomy(16), and in cases of with acoustic neuroma, multiple 
sclerosis(17), and neuropathy(16).
Only few studies have investigated the auditory pathway in 
PKU individuals. In a recent study(18), compared to the control 
group, the PKU group showed impairments during basic au-
diological evaluation, as shown by the poor air-conducted and 
speech reception thresholds and low speech recognition indi-
ces, in addition to an increase in the stapedial reflex thresholds.
Studies evaluating brainstem auditory evoked potentials 
(BAEPs) have shown some differences after comparing the 
results obtained from individuals with PKU and from those 
of the control group. In a study, which BAEPs were studied 
in pediatric patients with different neurological disturbances, 
an increase was observed in the I-V interpeak latency of these 
potentials in a child with untreated PKU at 14 months of age(19).
A prospective longitudinal study analyzed the develop-
ment of BAEPs during the first year of life in eight children 
with early-treated PKU and 58 children without PKU. Thus, 
it was concluded that the average I-V interpeak latency was 
significantly greater in the group of children with PKU than 
in children from the control group. The three principal com-
ponents of the BAEPs (i.e., I, III, and V waves) were present 
in all children with PKU throughout the first year of their life. 
Compared to the control group, the early-treated PKU group 
showed no differences between the neurophysiological audi-
tory parameters and biochemical or clinical signs(20).
In a systematic review, the presence of hearing impairments 
was considered related to PKU disease, with only few studies 
investigating this relationship, with controversial results. While 
some studies found impairments in the neurophysiological 
auditory parameters in PKU patients with early or late treat-
ment, others presented results within the normal limits. Hence, 
the authors concluded that the relationship between PKU and 
hearing impairments deserves further study to clarify possible 
peripheral and central hearing impairments in individuals with 
early-treated PKU(21).
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The proposal for this study emerged after monitoring re-
search and reviewing the literature, which showed a scarcity 
in studies evaluating OAE in children with PKU. Because this 
genetic disease causes impairments in myelination, and even 
individuals who have received early treatment present hearing 
impairments, as established in some studies by using BAEPs, it 
is necessary to evaluate the efferent auditory pathway in these 
individuals by OAE suppression.
The objective of this study was to evaluate the peripheral 
and central auditory pathway by basic audiological evaluation 
and suppression of transient otoacoustic emissions in children 
with early-diagnosed and treated PKU.
METHODS
A transversal study was conducted based on the compa-
rison between independent groups, which was approved by 
the Research Ethics Committee of UFMG (No. 062/07). The 
sample included 12 children with classic PKU (study group; 
age between 6 and 13 years) and 16 children without PKU 
(control group; age between 6 and 14 years). In the study 
group, we included only those children without any impair-
ment associated with PKU, such as prematurity, evidence 
or history of delays in neuropsychomotor development, and 
evident sensory, neuromotor, or psychocognitive impairment. 
Children with PKU were screened by NUPAD-MG and tre-
atment was initiated to up to 80 days after birth. The control 
group comprised children recruited from the Pediatric Outpa-
tient Clinic of the home institution to ensure equivalence in 
the socio-economical level of the two groups. The following 
inclusion criteria were considered for the control group: type 
A, tympanometric curve with the presence of contralateral 
stapedial reflexes on immittance testing; absence of prior 
history of recurrent otitis; absence of cerumen in the external 
acoustic meatus; absence of developmental delays or other 
sensory, neuromotor, or psychocognitive impairment; children 
born at term with appropriate weight for their gestational age; 
and children whose guardians have agreed to participate in the 
study and have signed the informed consent form.
The data were collected at the Audiology Service of the 
Hospital das Clínicas of UFMG. The audiological evaluation 
began with meatoscopy, followed by immittance testing, 
involving the determination of the tympanometric curve and 
study of contralateral stapedial reflexes at frequencies of 500 
Hz, 1, 2, and 4 kHz. The tympanometric tests were conducted 
using Interacoustics® AZ7 impedance audiometer, and the 
results were used for classifying the patients on the basis of 
the criteria proposed by Jerger(22).
After this, a study of audibility thresholds through air and 
bone conduction was conducted using the Interacoustics® 
AD229-b audiometer, and the results were used for classifying 
the patients on the basis of the criteria by Davis, Silverman(23). 
The speech audiometry involved determination of the speech 
discrimination scores (SDS) and speech recognition thresholds 
(SRT) bilaterally. The OAE study was conducted following 
this in an acoustically insulated room by using the Bio-logic® 
AuDx system for recording. White noise of 60 dB intensity was 
applied to the contralateral ear through a TDH-39 headphone.
After data collection, those of interest to this study were 
analyzed and compared to investigate possible hearing im-
pairments of children from different groups. The database 
was structured using Excel, and the statistical analysis was 
conducted using Statistical Package for the Social Sciences 
(SPSS) version 15.0. Descriptive statistics, including measures 
of the central tendency (average) and dispersion (standard 
deviation), and frequency, were used to characterize children 
from both the groups in relation to demographic variables; 
further, these were used to describe the responses obtained 
in each group. For the analysis of dependent variables, a 
comparison was first made between the ears of the study 
patients by using the paired t test. In case no differences were 
detected, then the variables were compared between groups 
by using the t test for independent groups or Mann-Whitney 
U test, when deemed more appropriate (non-Gaussian 
distribution). For qualitative dependent variables, the com-
parison between groups was conducted using Chi-squared 
test. In all analyses, the level of significance was considered 
as α=0.05.
RESULTS 
The intergroup distribution of children in relation to age, 
gender, and start of treatment was equal (Table 1). The ave-
rage age of the control group was 10 years and that of the 
study group was 10 years and 4 months, with no intergroup 
difference (p=0.160).
The analysis of the results from all the evaluations was 
initiated by comparisons between that of each ear, with di-
fference only for the variable related to the air-conducted 
thresholds (p=0.028). For all other variables, the average of 
the values obtained in both the ears was considered for inter-
group comparisons.
In relation to the basic audiological evaluation, the air and 
bone-conduction audibility thresholds were within the standard 
patterns, and no intergroup difference for the thresholds was 
obtained (p=0.870 and p=0.652, respectively). In the speech 
audiometry, the SRT was within normal limits in both the 
groups (p=0.416). However, an intergroup difference was 
observed for SDS (p=0.049) (Table 2).
In immittance testing, a type A tympanometric curve was 
observed in all study participants. In relation to contralateral 
stapedial reflexes, children from the study group presented an 
Table 1. Distribution of children in relation to age, gender and start 
of treatment
Variables
Control Group 
(n=16)
Study Grup 
(n=12)
Mean age in years (SD) 10.0 (2.2) 10.4 (2.1)
Start of treatment in days of 
life (SD) - 34.6 (23.4)
Gender (n)
Male 9 6
Female 7 6
Note: SD = standard deviation
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increase in their thresholds at frequencies of 2 kHz (p=0.032) 
and 4 kHz (p=0.047).
The study of transient OAE did not show any intergroup 
difference for average OAE with noise (p=0.052), without 
noise (p=0.160), and suppression (p=0.530). Further, no di-
fference was obtained after comparing OAE between the right 
and left ears without noise (p=0.932), with noise (p=0.733), 
or suppression (p=0.468) (Table 3).
DISCUSSION
In relation to the time between birth and start of PKU tre-
atment, the average was 34 days (Table 1). In this study, the 
criterion for inclusion in the study group was diagnosis and 
start of treatment by the 80th day after birth. Although from 
the literature, it is recommended that treatment be started by 
21 days after birth(1,8), some authors specify that the start of 
treatment by up to 90 days is desirable(3).
The air-conduction and bone-conduction thresholds were 
within the normal limits for both the groups. This result was 
expected because tonal audiometry threshold evaluates peri-
pheral hearing; further, serum accumulation of phenylalanine, 
which leads to biochemical impairments in the central nervous 
system, affects the myelination process and does not interfere 
with the functioning of the middle and/or inner ear. In case 
demyelination has occurred in the auditory nerve or in the 
brainstem auditory pathways, the normality of the auditory 
thresholds is not be observed, because in cases of retroco-
chlear hearing loss, the audiometric results generally show 
bilateral symmetric or asymmetric hearing loss of a mild to 
acute degree(24). In cases of lesions in the more central areas of 
the auditory pathway, which manifests in auditory processing 
disorders, individuals may present normal tonal thresholds(25), 
as observed in the PKU group.
Type A tympanometric curve was observed for all partici-
pants, which showed normality in the functioning of the middle 
ear. This result was expected, because the symptoms associated 
with PKU do not include interferences in the functioning of 
the middle ear, as mentioned earlier. Further, the type A curve 
was expected with respect to impairments in the retrocochlear 
auditory pathways of children with PKU.
Regarding contralateral stapedial reflexes, there was a 
difference in comparison between the groups for frequencies 
of 2 and 4 kHz, with the PKU group showing high threshol-
ds. This increase in the acoustic reflex thresholds was also 
observed in another study on children with PKU(18). A normal 
tympanogram and stapedial reflexes are strong indicators of 
the integrity of the middle ear and absence of hearing loss 
at a severe or acute level. It is known that individuals with 
auditory processing disorder may present impairments in 
acoustic reflexes that are evidenced as absence or increase 
in their reflex thresholds(25), without impairments in the tonal 
audiometry. Therefore, these patients may present pathological 
manifestations of the central auditory nervous system(26), and 
they should be referred for evaluation of auditory processing.
In speech audiometry, the SRTs for both the ears were 
within normal limits, with no intergroup differences. It must 
be stressed that these results confirm the air-conduction au-
dibility thresholds(27), which were also within normal ranges 
for all participants. 
Intergroup differences were observed for SDS with the 
PKU group showing poor averages. This poor performance of 
children with PKU may also indicate deficits in the processing 
of auditory information. Another recent study showed higher 
Table 2. Pure-tone and speech audiometry, and contralateral stapedial reflexes thresholds in all groups
Variable
Control Group 
(n=16)
Study Group 
(n=12)
p-value
RE 
Mean (SD)
LE 
Mean (SD)
RE 
Mean (SD)
LE 
Mean (SD)
Pure-tone thresholds (in dBHL) 6.8 (3.8) 5.1 (4.6) 7.8 (5.8) 6.9 (4.6) 0.870
SRT (in dBHL) 13.4 (7.9) 11.6 (7.5) 15.8 (9.0) 15.4 (6.6) 0.416
SDS (in %) 97.5 (3.5) 98.0 (3.3) 94.7 (3.9) 96.7 (3.7) 0.049*
SR thresholds (in dB) 500 Hz 97.2 (6.6) 97.8 (7.9) 100.8 (7.6) 101.2 (9.3) 0.427
1 kHz 94.7 (6.4) 95.3 (6.2) 99.2 (6.7) 100.4 (7.5) 0.204
2 kHz 92.8 (7.1) 92.2 (9.5) 100.4 (8.6) 97.5 (6.6) 0.032*
4 kHz 95.3 (10.4) 96.6 (11.5) 100.4 (13.7) 102.1 (11.8) 0.047*
* Significant values (p≤0.05) – t test
Note: SD = standard deviation; SRT = speech reception threshold; SDS = speech discrimination score; SR = stapedial reflexes; RE = right ear; LE = left ear 
Tabela 3. Resultados obtidos para as EOA
OAE (in dBSPL) Control Group (n=16)
Study Group 
(n=12)
Without noise
Mean (SD) 14.9 (4.1) 13.7 (5.3)
Minimum 7.4 1.7
Maximum 21.7 21.2
p-value 0.052
With noise
Mean (SD) 13.8 (4.0) 13.3 (5.7)
Minimum 7.6 -1.8
Maximum 20.8 21.3
p-value 0.160
Suppresion
Mean (SD) -1.1 (1.2) -0.4 (1.8)
Minimum -3.5 -5.0
Maximum 1.2 2.9
p-value 0.530
t-test (p≤0.05)
Note: OAE = otoacoustic emissions; SD = standard deviation
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SRT and poorer SRT performance in the PKU group than in 
the control group(18). Because excess levels of PKU causes defi-
ciency in the production of neurotransmitters, an investigation 
of the more central auditory areas is necessary to discard the 
possibility of lesions in the auditory pathway of these patients.
The analysis of OAE suppression did not show any inter-
group difference, showing the integrity of the medial olivoco-
chlear efferent system in children with PKU. No studies were 
found in the literature that showed OAE results in individuals 
with PKU that could be compared with the findings of this stu-
dy. Based on this finding and considering the results obtained 
in studies performed with BAEPs in individuals with PKU, it 
can be speculated that the auditory pathway of these children 
showed impairments originating from the brainstem. This is 
why no impairments were observed during transient OAE sup-
pression, which clarified the functioning of the efferent system 
and the interaction between the afferent and efferent pathways. 
As a limitation of the study, the sample was relatively small, 
which might have interfered with the findings in this study.
CONCLUSION
Basic audiological evaluation by audiometry could not 
identify hearing impairments in children with PKU. The spe-
ech audiometry analysis showed poorer results for SDS in the 
PKU group, and evaluation of the stapedial reflexes showed 
that children with PKU show high thresholds at 2 and 4 kHz, 
which may indicate the deficits in the processing of auditory 
information.
The evaluation conducted by OAE suppression did not 
show the differences between children with and without the di-
sease, indicating that children with early-diagnosed and treated 
PKU do not show damages to the efferent auditory pathways.
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RESUMO
Objetivo: Avaliar a via auditiva de crianças com fenilcetonúria tratadas precocemente, por meio de audiometria, imitanciometria e 
supressão das emissões otoacústicas transientes. Métodos: Estudo prospectivo transversal comparativo com amostra composta por 28 
crianças, sendo 12 com fenilcetonúria e 16 sem a doença. Foi realizada a pesquisa dos limiares de audibilidade por via aérea e óssea, 
logoaudiometria, imitanciometria e supressão das emissões otoacústicas transientes. Resultados: A audiometria e a logoaudiometria 
estiveram normais em todos os participantes. Foram encontrados piores resultados para o índice de reconhecimento de fala (IRF) no 
grupo com fenilcetonúria. A imitanciometria revelou curva normal para todas as crianças, mas a pesquisa dos reflexos estapedianos 
demonstrou que as crianças do grupo com fenilcetonúria apresentaram aumento nos seus limiares nas frequências de 2 e 4 kHz. 
A supressão das emissões otoacústicas transientes não revelou diferença na comparação entre os grupos. Conclusão: A avaliação 
audiológica básica não identifica alterações na audição das crianças com fenilcetonúria, mas há pior discriminação ao IRF e aumento 
nos limiares de reflexos estapedianos nessas crianças, podendo indicar distúrbios do processamento auditivo. O estudo da supressão 
das otoemissões demonstra integridade do sistema eferente olivococlear medial nas crianças com fenilcetonúria. 
Descritores: Audição; Fenilcetonúrias; Células ciliadas auditivas; Transtornos da audição; Emissões otoacústicas espontâneas
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